Stay updated on Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Sign up to get notified when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This reflects a new release version and does not change study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-07-27T06:23:01.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a post-release update to the study record.
    Difference
    0.0%
    Check dated 2026-07-05T13:37:38.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    A minor page software/UI update updated the revision from v3.6.0 to v3.6.2, with no evident changes to the study content or participant information.
    Difference
    0.0%
    Check dated 2026-06-28T08:40:23.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Removed sponsor-related branding and multiple study-support resources from the Study Details page, including the Investigator Inquiry form and various helpful links and documents; this alters how users can contact investigators and access trial materials.
    Difference
    0.3%
    Check dated 2026-06-21T02:16:05.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    Added user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice ('No longer looking for participants'); updated the Intervention/Treatment label from 'Intervention / Treatment' to 'Intervention/Treatment' and bumped the site revision to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-14T03:24:33.000Z thumbnail image
  9. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, representing a new build/version of the page without altering displayed study details.
    Difference
    0.0%
    Check dated 2026-06-06T22:35:08.000Z thumbnail image

Stay in the know with updates to Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 3 Daclatasvir/Asunaprevir in Hepatitis C Clinical Trial page.